The Pharmaceutical Industry. Industry introduction Opportunity How to get into this industry ?

Slides:



Advertisements
Similar presentations
Eli Lilly and Company – Tailored Therapeutics and Diagnostics © Eli Lilly and Company 2012 The views and opinions expressed herein and/or during the accompanying.
Advertisements

Pharma/BIOTECH industry overview
Patrick Vallance Head of Drug Discovery GlaxoSmithKline
BUY Recommendation: Gilead Sciences (GILD). Company Overview Gilead Sciences, Inc. is a research-based biopharmaceutical company found in 1987 that discovers,
Agenda Overview: the Bio-Pharma industry Major challenges for developers Genzyme: Innovations for unmet medical needs.
Efficiency, Ethics and Cost in Pharmaceutical Research and Manufacturing Matthew Wirtala Spring 2006.
Copyright © 2012 Quintiles An Industry View of Working in NHS Wales Paula Jefferies – Site Relationship Manager Quintiles 11 th December 2012.
S TRATEGY IN THE TWENTY - FIRST CENTURY PHARMACEUTICAL INDUSTRY : M ERCK & C O. AND P FIZER INC. MGMT 495 Summer 2011: Kelly Bossolt Marta Kovorotna Sarah.
What is a Generic Medication?. The World Health Organization Definition of a Generic Medication A generic drug is a pharmaceutical product, usually intended.
The Global Generic Medications Market
PFIZER, Inc Company Valuation Krastina Dzhambova.
Ethics February 23rd. Merck: Background Most admired company in America for 7 straight years in the 80s Edward M. Scolnick (Brilliant) in charge of Merck.
Technology and Health Care HCA 701 November 10, 2005.
 Broad-based health care company that discovers, develops, manufactures, and markets products and services  Abbott's main businesses: ◦ Global pharmaceuticals.
Medication Use. Discussion Question #1 “Drugs represent one of the classical conundrums of life. We can’t live with them; we can’t live without them.”
SUCCESS FACTORS IN THE PHARMACEUTICAL MARKETPLACE
More on Generic Drugs Global Classrooms 2013 Rachel Hunkler.
ABBOTT Investment Managers: Jonathan Barki Su Chen Lele Liang (Layla)
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
Research & Innovation Horizon societal challenge 1 Open Info Day Funding Opportunities for SMEs Horizon 2020 "Health, demographic change and wellbeing"
Sabena Ahmad Iveta Smincakova Dawn Bradbury. Political:  Lighter Regulatory Controls (1960s)  Tighter Regulatory Controls on Clinical trials (1970s)
Drug Pricing in Canada Victoria Brown, Anureet Sohi, Lisa Weger SPHA 511.
Michelle Boudreau, Vice President, Private Markets, March 11, 2015 Presentation to CADA.
Pharmaceuticals: Lecture Outline Introduction 1.Historical Development of Pharmaceuticals 2. Modern Uses & Canadian Health Care 3. Doctors & Pharmaceuticals.
1 Global New Employee Orientation Workshop Welcome.
Pharmacology II. The Business of Sick.
Stages of drug development
Chapter 1.3.  Sell 1 group of similar products.  Ex. The protocols for manufacturing recombinant human growth hormone are almost identical to those.
STRATEGIC MANAGEMENT 1 Irina Raynaud Pierre Jean Tessier Nicolas Cabrit Clément Tumoine.
The Truth About the Drug Companies Marcia Angell, M.D.
The Business Research Company Healthcare. Typical Healthcare Projects Copyright TBRC Business Research. All Rights Reserved. 2 Market Analysis Product.
Political Pressure on margins offer tax or cost advantages Price or reimbursement controled by the government Economic Mergers between Biothecs Mature.
Pfizer Incorporated. Beginning Founded by cousins Charles Pfizer and Charles Erhart in 1849 Goal Discover and develop new and better ways to prevent and.
S TRATEGY IN THE TWENTY - FIRST CENTURY PHARMACEUTICAL INDUSTRY : M ERCK & C O. AND P FIZER INC. MGMT 495 Summer 2011: Kelly Bossolt Marta Kovorotna Sarah.
Todd Hamilton District Sales Manager. Innovation  On average it takes scientists, physicians, engineers, and other researchers between 10 and 15 years.
Intellectual Property and Innovation … The Virtuous Cycle Khaled Mansour Area Managing Director, Janssen, Middle East, West Asia and Africa.
Advertising in the Pharmaceutical Industry
1 Intellectual Property in the Innovative Pharmaceutical Industry *** June 12, 2006 Gregg C. Benson Assistant General Counsel – Intellectual Property 1.
HSCI 678 Intro to US Healthcare System Biomedical Research, Technology, and Assessment Chapter 10 Dr. Tracey Lynn Koehlmoos.
Nathan Mendes Ronnie Ng Scott Perkins Zvi Rhine Zack Weaver Symbol: MRK Exchange: NYSE 12/4/2000.
The State of the Massachusetts Life Science Industry - The Year in Review - June 2, 2011 MALSI | MA Life Sciences Innovation Day.
Drug Delivery and Generic Medicine The Challenge ahead; Choose where to play. MENA as an Industry Model Mohammad Refaat Khattab Cairo University; Egypt.
Merck & Co., Inc. Recommendation Sell Yuqian(Annie) Zhang Nov. 4 th, 2004.
Developing medicines for the future and why it is challenging Angela Milne.
PUTTING THE PATIENT AT THE CENTER OF HEALTHCARE RESEARCH Towards a more inclusive model.
Sucampo Pharmaceuticals, INC.. Overview Background: Sucampo is a pharmaceutical company focused on the development and commercialization of medicines.
HSC 6636: Pharmaceuticals & Medical Technology 1 Dr. Lawrence West, Health Management and Informatics Department, University of Central Florida
Consolidation in the Pharmaceutical Industry
Ari Lazar, Gabriella Wang, Jessica Kan, Sai Poddutur Presented 4/7/15
Issues related to poor IP protection in EMs: Pharmaceutical Example Rob May Commercial Director, Janssen, EMEA Emerging Markets.
Confidential and Proprietary Information © 2014 Express Scripts Holding Company. All Rights Reserved. 1 Confidential and Proprietary Information © 2014.
© Copyright 2004 Frost & Sullivan. All Rights Reserved. World Psychiatric Therapeutics Markets Loss of Patent Protection Challenges Market Growth Pharmaceutical.
Rigid Endoscopes : Medical Device Industry Research And Analysis
Endoscopy Visualization Systems - Medical Devices Pipeline Assessment
Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2016
Nucleus Replacement Medical Devices Market Size, Share & Forecast
Cancer Supportive Care Market Forecast Projections to 2022 on a Global Level Published: Mar 2017 Single User PDF: US$ 4995 Order this report by calling.
© Coherent market Insights. All Rights Reserved BIOSIMILAR PIPELINE ANALYSIS MARKET Global Industry Insights, Trends, Outlook, and Opportunity Analysis,
Success Stories of Globalization in Korean Pharma
Research & development
Free Trade and Intellectual Property Rights: Implications for the Canadian Pharmaceutical Environment Joel Lexchin MD School of Health Policy & Management.
BASICS IN PHARMA.
Drug Management Updates
Antidiabetics Market share to grow at 10.5% CAGR from 2016 to 2024
An Increasing Demand for Prescription Drugs Drives Profitability
Median submission gap, median approval time and percentage approved as expedited for new active substances (NASs) approved by six authorities:
Investment Opportunity and
INTERNATIONALISATION – FOCUS ON EMA AND FDA
Patient Choice Act ….for those you love.
Global Specialty Pharmaceuticals Market. Report Description and Highlights According to Renub Research report "Specialty Pharmaceuticals Market, by Country.
Presentation transcript:

The Pharmaceutical Industry

Industry introduction Opportunity How to get into this industry ?

Major Multinational Corporations

Brand-name drug vs. Generic drug Brand-name drug ( 原廠藥 ) Newly developed Under patent protection Generic drug ( 學名藥 ) Chemically identical to the brand-name drug Can start selling after the patent expires Also requires FDA approval Lower cost & Lower price Ex. Brand-name: Tylenol ® Generic name: Acetaminophen

Prescription drugs vs. OTC Over-the counter drugs (OTC) Do NOT require a doctor's prescription Prescription drugs Requires a doctor’s prescription

Eli Lilly & Company NEUROSCIENCE DIABETES ONCOLOGY BONE MUSCLE JOINT CARDIOVASCULAR MEN'S HEALTH

Research and Development Patent Protection: 20 years (Have to apply at very early stage of R&D) Average length of time from discovery to patient: 10 to 15 years Average cost to discover and develop a new drug: $800 million to $1.2 billion Video:

Industry Characteristics Highly regulated by regulatory authorizes (ex. FDA, EMEA) R&D is crucial: – Speed of Innovation Reduce timeframe of development  extend time of selling under patent protection Be the First in market! Ex. Viagra (Pfizer) vs. Cialis (Eli Lilly) – Pipeline The set of compounds under development An important indicator of the value and future prospects of a company tml What to do when running out of pipelines? M&A? Invest more in R&D? – Patent

Taiwan Market Pharmaceutical Industry market scale: 3.8 billion USD 1% of global total market scale

Taiwan Market - Top 5 local players 1. Yung Shin Pharm. IND.CO. LTD 2. Gentle Pharm 3. TTY Biopharm 4. Standard Chem & Pharm Co., LTD. 5. Synmosa Biopharma Corporation

Opportunity We not only selling drugs, we save lives!

Opportunity Pharmaceutical company organization Possible opportunity Primary care - CV and AIR Specialty care - Oncology - HIV - ID - V & WM Medical - RA -MA - CO Supporting group: FA, HR, PR, IT, PR and SMS

Source:

Clinical Research Associate

Monthly Calendar

Working as a CRA Experience sharing - TRACER CASE - Oncology Trial Love LifeLove Life The truth about the drug company

Thanks for your attention!